• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA¿ SINGLE PORT MAXZERO¿ CLOSED IV CATHETER; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA¿ SINGLE PORT MAXZERO¿ CLOSED IV CATHETER; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Model Number 383557
Device Problems Crack (1135); Fluid/Blood Leak (1250); Leak/Splash (1354); Separation Problem (4043)
Patient Problem Pain (1994)
Event Date 02/08/2023
Event Type  Injury  
Event Description
It was reported that during use with bd nexiva¿ single port maxzero¿ closed iv catheter leakage occurred and tubing was discovered to be damaged.Patient had order from 4mg ivp of morphine but due to having to remove piv.Pain treatment was switched to tylenol 1000mg po.The following information was provided by the initial reporter: (1st of 3 occurrences).Patient was taken to ct (study was without contrast).Patient was brought back to emergency department and nurse noted bleeding from iv site.Iv was removed and secured.
 
Manufacturer Narrative
There were multiple medical device types reported to be involved.The information for the additional device type is as follows: medical device type: foz.Common device name: intravascular catheter.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Manufacturer Narrative
After further review of the customer's event description, the following fields have been updated with corrections: b5: describe event or problem: it was reported that during use with bd nexiva¿ single port maxzero¿ closed iv catheter separated from hub and leakage occurred.Patient had order from 4mg ivp of morphine but due to having to remove piv.Pain treatment was switched to tylenol 1000mg po.H6: imdrf annex a grid: a1503, a0504.
 
Event Description
It was reported that during use with bd nexiva¿ single port maxzero¿ closed iv catheter catheter separated from hub and leakage occurred.Patient had order from 4mg ivp of morphine but due to having to remove piv.Pain treatment was switched to tylenol 1000mg po.The following information was provided by the initial reporter: (1st of 3 occurrences) patient was taken to ct (study was without contrast).Patient was brought back to ed and nurse noted bleeding from iv site.Iv was removed and secured.
 
Manufacturer Narrative
The following fields have been updated due to additional information: d.9.Device available for eval?: yes.D.9.Returned to manufacturer on: 07-mar-2023.H.6.Investigation summary: our quality engineer inspected the representative samples and photographs submitted for evaluation.Bd received 642 sealed 20g x 1.25in.Nexiva units from lot number 2250144.Additionally, three photos were provided for investigation.The photo labeled ¿unknown incident.Png¿ displayed a used 20g nexiva unit.The extension tubing was not visible however it is evident that it was separated from the catheter adapter.No tubing remnants can be seen inside the catheter adapter, ruling out the possibility that the tubing was severed.Therefore, it is likely that the tubing separated due to a lack of adequate adhesion between the extension tubing and catheter adapter.Both photos show a used 20g nexiva unit.In both units the extension tubing can be seen separated from the catheter adapter.The end of the extension tubing appears undamaged, and no tubing remnants can be seen inside the catheter adapter.This evidence rules out the possibility that the tubing was severed.Therefore, it is likely that the tubing separated due to a lack of adequate adhesion between the two components.A gross visual inspection of the returned units did not identify any damage to the components.A sampling of 125 units were inspected.To verify that the extension tubing was adequately adhered to the catheter adapter, the units were first leak tested.During removal of the units from the sealed packaging, two units had the extension tubing separate from the catheter adapter when lightly pulled on the extension tubing.During leak testing, one unit immediately separated upon flushing.All other units passed leak testing.Given the ease with which the defective units separated, it is likely that no adhesive was present on the components.This was verified by microscopic inspection which found no traces of adhesive on the extension tubing or inside port of the winged adapter.This indicates that adhesive was not dispensed properly during manufacturing and thus failed to adhere the two components together.A device history record review showed no non-conformances associated with this issue during the production of this batch.The appropriate personnel have been notified and we appreciate you taking the time to bring this observation to our attention.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business team regularly reviews the collected data for identification of emerging trends.H3 other text : see h10.
 
Event Description
It was reported that during use with bd nexiva¿ single port maxzero¿ closed iv catheter catheter separated from hub and leakage occurred.Patient had order from 4mg ivp of morphine but due to having to remove piv.Pain treatment was switched to tylenol 1000mg po.The following information was provided by the initial reporter: (1st of 3 occurrences).Patient was taken to ct (study was without contrast).Patient was brought back to ed and nurse noted bleeding from iv site.Iv was removed and secured.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA¿ SINGLE PORT MAXZERO¿ CLOSED IV CATHETER
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8448235433
MDR Report Key16492949
MDR Text Key310780896
Report Number1710034-2023-00187
Device Sequence Number1
Product Code FPA
UDI-Device Identifier30382903835578
UDI-Public(01)30382903835578
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K170336
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 04/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/06/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number383557
Device Catalogue Number383557
Device Lot Number2250144
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/12/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/07/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-